Introduction: Patients with CF present numerous pathological conditions such as malnutrition, depletion of fat-free mass, metabolic disturbances (abnormal glucose metabolism, increased insulin resistance, chronic energy deficit, local and chronic inflammation), which could affect or be associated with altered adipokines concentration.
Introduction
Cystic fibrosis (CF) is an untreatable and lifeshortening inherited autosomal recessive disease with multiorgan manifestation. It is caused by different mutations in a single gene, localized on the long arm of chromosome 7 at position q31.2., which codes Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). CFTR protein is a cAMP-activated chloride channel expressed at the apical membrane on the surface of epithelial cells lining the airways, gastrointestinal tract, cells of exocrine pancreas, airway submucosal and sweat glands [1] . To date, more than 1900 mutations of the CFTR gene have been identified. DF508 -deletion of phenylalanine 508 is the most prevalent mutation, with approximately 90% of all CF patients carrying it on at least one allele, and unfortunately it is associated with a severe clinical phenotype. The defective or absent CFTR protein results in poor transport of salt and water into and out of the cells in number of organs. The extent of clinical manifestations is highly heterogeneous in distinct organs. Leading symptoms of typical CF include increased electrolytes concentration in sweat, exocrine pancreatic insufficiency and progressive pulmonary dysfunction, which is responsible for more than 80% of CF-related deaths [1] . CF-associated bronchopulmonary disease is characterized by multiply alterations including mucostasis, mucus hypersecretion, and chronic neutrophilic inflammation with recurrent bacterial infections, mainly caused by Pseudomonas aeruginosa and Staphylococcus aureus [2, 3] .
Other CF clinical manifestations comprise chronic rhinosinusitis, hepatic and intestinal disorders, diabetes mellitus, male infertility [1] . Cystic fibrosis is associated with malnutrition, depletion of body fat, but increased percentage of visceral adipose tissue [4, 5] .
Adipokines are protein mediators secreted by the adipose tissue, which were found to be associated with the chronic low-grade inflammation process present in inflammatory diseases and chronic disturbances of metabolism [6] [7] [8] [9] . With related receptors extensively dispersed throughout the body, including the lungs, adipokines may be a contributing factor underlying the complications of CF.
We have planned to investigate serum levels of selected adipokines such as resistin, apelin, adiponectin to demonstrate their application as possible markers of inflammation.
Resistin is expressed in brown and white adipose tissue and is a member of cysteine rich proteins family, called resistin -like molecules (RELMs), also known as the FIZZ family (found in inflammatory zones). Circulating monocytes and macrophages seem to be responsible for resistin production in human. Resistin has proinflammatory properties and upregulates the expression of monocyte chemo-attractant protein-1 (MCP-1) as well as vascular cell adhesion molecule -1 (VCAM-1) and intercellular adhesion molecule -1 (ICAM-1) in endothelial cells, which have been known to contribute in the pathogenesis of inflammation [10, 11] .
Adiponectin is a well-known adipokine that has anti-diabetic, anti-inflammatory and anti-oxidative effects [12] . Low serum adiponectin levels are related to obesity, insulin resistance, diabetes mellitus and cardiovascular disease, and lipodystrophy [8, 9] . On the other hand higher adiponectin serum levels have been reported in patients with deficits of energy in anorexia nervosa and bulimia and patients with bronchiectases with fat-free depletion or CF [5, 8, 9] .
Apelin (APE) is a novel bioactive peptide identified as the endogenous ligand of the previously discovered "orphan" G-protein-coupled receptor named APJ, isolated by Tatemoto et al. [13] from bovine stomach extracts in 1998. Several different isoforms of APE have been identified that are thought to exist in vivo. The predominant form of circulating APE is believed to be APE-36; however, shorter C-terminal fragments with biological activity have been found, including APE-17, APE-16, APE-13 and its pyroglutamylated form (APE-p[Glu]-13), and APE-12 [14, 15] . It has been demonstrated that the biological activity of APEs is related inversely to the peptide length; thus, APE-12 is the most potent isoform. APE belongs to the adipokines group because its mRNA expression has been demonstrated in mature adipocytes and vascular stroma of fat tissue in rodents and humans as well as in murine preadipocyte cell lines (3T3F442A) [16, 17] . APE peptide expression has been also detected in CNS neuronal cells (APE-p[Glu]-13 and APE-17), placenta, breast in pregnant and lactating women (APE-36 and APE-p[Glu]-13), pancreas, kidneys, prostate, testes (APE-36), uterus (APE-36), gastrointestinal tract, and osteoblasts [18, 19] .
This multifunctional apelinergic system is also highly expressed in pulmonary tissue. APJ is expressed in bronchial and alveolar epithelial cells, in small pulmonary blood vessels in the endothelium and in the smooth muscle cells [20] .
Only a few reports conducted in adult patients with CF focus on the pro-inflammatory role of leptin and anti-inflammatory of adiponectin, which potentially may affect inflammation and glucose tolerance as well as nutritional status in this group [5, 21, 22] . However, recent human data are inconclusive regarding the independent association between serum leptin or serum adiponectin and CF symptoms severity in adults.
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The potential association between CF and resistin and apelin has not been explored in CF so far and remains obscure. We hypothesized, that resistin, apelin and adiponectin also participate in CF pathophysiology and are associated with the severity of CF clinical features.
Material and methods
The study group comprised 21 children (aged 4.5-18 years; mean age 11.34 ± 0.37 years) with stable CF. The diagnosis of CF was established by sweat test and later confirmed by genetic tests in all subjects. All patients were treated according to European and U.S. guidelines [24] . Patients with pulmonary exacerbation were excluded from this study. In all children the following parameters were assessed: patient history and physical examination, anthropometric parameters, sputum and blood samples, and lung function tests.
The control group consisted of 22 healthy children (aged 4-17 years; mean age 10.9 ± 4.4years). Children from the control group attended the outpatient pediatric clinic for non-immunological, non-inflammatory health problems and needed venous puncture.
The present study was approved by Ethics Committee of the Medical University of Silesia in Katowice and written informed consent was obtained from children's parents.
Laboratory assays
Blood samples for assays were collected in the fasting state between 8-9 30 am. After centrifugation at 1000 × g for 15 min at 4°C, the serum samples were frozen at -20°C until analyzed. The absorbance measurements for all samples were performed using the Quant Universal Microplate Spectrophotometer (BioTek Instruments Inc., Winooski, VT) determined on the basis of the standard curve made for a series of dilutions of the standards available in the kit. Acquired data were analyzed using KCJunior Software (v.1.31.5, Bio-Tek Instruments,Winooski, VT, USA).
Serum resistin concentration was measured by commercially available enzyme-linked immunosorbent assay kit (Mediagnost, Reutlingen, Germany) as described in our previous study [24] . The concentration of resistin was determined on the basis of standard curve carried out for serial dilution available in kit standards (human recombinant resistin). Immunocomplex detection was determined on the basis of reaction with rabbit polyclonal antibody antihuman immunoglobulin (IgG) conjugated with horseradish peroxides and then with TMB substrate solution (TMB substrate, slow kinetic, Sigma-Aldrich, St. Louis, MO, USA). The sensitivity for resistin was 0.012 ng/mL, and the intra-and interassay CV was 4.66% and 4.79%, respectively.
Serum apelin-12 concentration was determined using commercial human Apelin-12 enzyme immunoassay kit (Phoenix Pharmaceuticals Inc., Burlingame, CA) following the manufacturer's instructions as described in our previous study [25] . Serum samples were extracted before the assay, to isolate analyzed peptides. Buffer A (1% trifluoroacetic acid aqueous solution), buffer B (60% acetonitrile solution in 1% trifluoroacetic acid solution), and SEP-PAK C chromatographic columns (Waters Associates, Milford, MA) were used for extraction. Before the analysis, after lyophilisation, obtained extract was dissolved in the assay buffer.
The sensitivity was 0.07 ng/mL for Apelin-12 kit; the intraassay coefficient of variance (CV) was 5% or less, and the extraassay CV was 14%.
Serum adiponectin concentration was measured by commercially available enzyme-linked immunosorbent assay kit (Bio-Vendor, LLC, USA). The procedure was done according to manufacturer 's instruction. The sensitivity for adiponectin was 0.7 ng/mL, and the intra-and interassay CV was 7.0% and 8.2%, respectively.
All statistical analyses were performed using (MedCalc ver. 12.4.0.0) and p values of < 0.05 were considered to be significant. To compare the characteristics of the subgroups the Mann-Whitney U-test was applied. Correlations were analyzed with Spearman tests. Besides absolute values of examined adipokines concentration in serum we additionally expressed results in relation to BMI as apelin/BMI, adiponectin/BMI and resistin/BMI ratios.
Results
The characteristics of 20 children with CF and 22 healthy control subjects is presented in Table I . Mean values of BMI in CF group were significantly lower than in control group.
The mean values of serum levels of adiponectin, apelin, resistin in all children are shown in Table II .
Serum levels of resistin were significantly higher and adiponectin significantly lower in CF children than in healthy children (p = 0.001 for resistin, p = 0.001 for adiponectin). There was no difference in serum apelin levels between two examined groups. However, values of adiponectin/BMI ratios and apelin/BMI ratios in CF did not differ significantly from controls, but still were observed significantly higher values of resistin/BMI ratios in CF in comparison to controls. Serum resistin/ adiponectin ratio was significantly higher in CF patients than in controls (p < 0.0001) (Fig. 1) .
We have documented few correlations between adipokine levels and other parameters. Age of CF PRACE ORYGINALNE (Fig. 2) . Serum resistin/ adiponectin ratio correlated negatively with FEV 1 /FVC (R: -0.49, p = 0.04) (Fig. 3) . Adiponectin and apelin showed no correlation with BMI and BMI-SDS, glucose, total cholesterol and LDL-, HDL-cholesterol, triglyceride serum levels and spirometric parameters.
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Discussion
CF patients present numerous pathological conditions such as malnutrition and depletion of fat free mass, metabolic disturbances including abnormal glucose metabolism, increased insulin resistance, chronic energy deficit, local and chronic inflammation, all of which could affect or be associated with altered adipokines concentration [1, [2] [3] [4] . The results obtained in the current study showed that there was significant increase of resistin, concentrations in CF children in comparison with healthy controls. The role of resistin in patients with CF has not yet been investigated, so to our best knowledge is the first report showing this pro-inflammatory adipokine increase in CF children.
Macrophage exposure to resistin has been shown to induce expression of tumor necrosis factor alpha (TNF-alpha) and IL-12, IL-6. Furthermore, in human epithelial cells, RELMb induced increased proliferation, mucin and growth factor production, suggesting a potential contribution to airway remodeling. Interestingly adiponectin inhibits some effect of resistin [8, 26, 27] . Increasing evidence indicates that resistin plays an important regulatory role in insulin resistance, and several pathological processes including asthma, cardiovascular disease, and inflammatory bowel disease [7, 24, [26] [27] [28] . In patients with asthma and chronic obstructive pulmonary disease resistin correlated negatively wit FEV1 [26] [27] [28] . In our previous study resistin/BMI ratio correlated inversely with FVC of asthmatic children [24] . In several pathophysiological conditions, plasma resistin concentrations have been associated with circulating pro-inflammatory mediators, including CRP [28] . In our study resistin levels correlated positively with CRP, which is a commonly recognized acute phase protein. Recently Ballantyne et al. [27] suggested that balance between resistin and adiponectin is important in asthma pathology and resistin/adiponectin ratio is a positive predictor of FEV 1 and is higher in asthmatics who have more severe disease. In our present study we also observed higher resistin/ adiponectin ratio in CF compared to controls, which indicate the relative excess of proinflammatory adipokine resistin and relative deficit antinflammatory adipokine -adiponectin. Moreover resistin/adiponectin ratio in CF inversely correlated with FEV 1 /FVC. 
PRACE ORYGINALNE
Resistin is also implicated in the development of atherosclerosis, by affecting the course of chronic inflammatory response and cell proliferation and differentiation. [35] . In our study, however we have not found relationship of adipokines with lipid metabolism parameters. The study evaluating the risk of atherosclerosis in patients with CF, which purpose is to examine CF patients in relation to the exogenous and endogenous factors that influence the course of the disease will put a new light on this topic [36] .
In our study serum adiponectin was significantly lower in CF group than in control group, but adiponectin /BMI ratio did not differ from healthy children. Adiponectin is primarily considered to be anti-inflammatory due to its dual role in inhibiting the effects of pro-inflammatory cytokines (e.g. TNF alfa induced IL-18, IL-6) and inducing expression of anti-inflammatory cytokines (e.g. IL-10 and IL1RA) [6, 7] . In low levels may be partially responsible for excessive inflammatory response which plays a key role in chronic bacterial infection and pulmonary exacerbation and lung function decline in CF patients.
One of the major characteristic symptoms of CF airways is chronic inflammation. The CF airways contain several proinflammatory mediators including TNF-alfa, IL-1 beta, IL-6, IL-8, MIF [2, 3] . It has been suggested that adiponectin may have a protective role in inflammatory lung disease such as asthma but not in patients with COPD [29] . Several studies investigated adiponectin levels in CF, with inconsistent results. In adult CF serum adiponectin concentrations were higher than in healthy subjects, especially in patients with normal nutrition and in patients with liver disease [5, 30] . In one study the lowest adiponectin concentration among young malnourished patients was shown [5] similarly to our study. In other study any alteration in adiponectin levels despite insulin resistance, glucose intolerance and subclinical chronic inflammation was detected [31] [32] [33] .
We did not observe any correlation between anthropometric parameters, BMI, BMI-SDS and lung function and adiponectin levels. On the other hand adiponectin concentration was negatively correlated with age of children. The discrepancy between studies could be related to different age, stage of disease and organ involvement, nutritional status, metabolic disturbance. Additionally above mentioned authors did not adjust results to BMI or to free fat mass to diminished the potential bias.
In our previous study we demonstrated that serum levels of another adipokine i.e. APE-12 and APE-12/BMI ratio are increased in asthmatic children, particularly in girls [25] . In our CF patients with relative malnutrition serum apelin concentrations were similar to controls. It is not surprisingly because increased apelin expression in adipose tissue could contribute to apelin plasma levels. It is assumed that the overproduction of apelin in obesity could be a protective mechanism before onset of an obesity-related disorder, such as hypertension or cardiovascular dysfunction [14, 15] . Well known proinflammatory cytokine Tumor necrosis factor-alpha (TNF-a), that has been implicated in many aspects of the airway pathology in asthma [34] , may act as a direct up-regulator of apelin expression in adipocytes in both obese and lean subjects.
In conclusion, a significant increase in resistin concentration expressed also as resistin/BMI, and resistin/ adiponectin ratios, observed in children with CF may suggests that this adipokine is involved in the inflammatory process underlying the disease and is related to worse spirometric parameters describing airways obstruction. Although this was a cross-sectional study with a relatively small sample size we believe that our data may create a pilot knowledge for further studies evaluating the possible role of adipokines in CF pathogenesis.
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